A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. 2007

Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
Discovery Research Laboratory, Shionogi & Co., LTD., Osaka, Japan.

BACKGROUND Atopic dermatitis is a chronically relapsing inflammatory skin disease. Animal models induced by relevant allergens play a very important role in the elucidation of the disease. The patients with atopic dermatitis are highly sensitized with mite allergens such as Dermatophagoides farinae (Df). Therefore, in the present study, we tried to develop a novel model for atopic dermatitis by repeated application with Df extract ointment. METHODS Df extract ointment was repeatedly applied to the back of NC/Nga mice together with barrier disruption. Atopic dermatitis-like skin lesions were evaluated by dermatitis scores, skin histology and immunological parameters. The effect of corticosteroid and calcineurin inhibitor was also examined. RESULTS Repeated application of Df extract ointment caused rapid increase in dermatitis scores. Clinical (skin dryness, erythema, edema and erosion) and histological symptoms (dermal and epidermal thickening, hyperkeratosis, parakeratosis and inflammatory cell infiltration) in this model were very similar to those in human atopic dermatitis. Serum total and Df-specific IgE levels were elevated in this model compared with normal mice, and draining lymph node cells isolated from the mice that exhibited dermatitis produced significant amounts of interleukin-5, interleukin-13 and interferon-gamma after re-stimulation with Df. Furthermore, current first-line drugs for the treatment of human atopic dermatitis, corticosteroid and tacrolimus ointments, were effective against the clinical and histological symptoms in this model. CONCLUSIONS These results suggest that the model we have established is useful for not only elucidating the pathogenesis of atopic dermatitis but also for evaluating therapeutic agents.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen

Related Publications

Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
December 2016, Asian Pacific journal of allergy and immunology,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
August 2016, Experimental dermatology,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
August 2014, Experimental dermatology,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
August 2015, Anticancer research,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
September 2015, International journal of molecular sciences,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
February 2017, Food chemistry,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
August 2017, The Journal of investigative dermatology,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
January 2013, Evidence-based complementary and alternative medicine : eCAM,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
April 2022, Food & function,
Mina Yamamoto, and Takayo Haruna, and Kiyoshi Yasui, and Hisashi Takahashi, and Miho Iduhara, and Shigeki Takaki, and Masashi Deguchi, and Akinori Arimura
January 2013, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!